Bluebird Bio Inc. buy Barclays PLC
Start price
31.12.24
/
50%
€0.37
Target price
31.12.25
€38.48
Performance (%)
-
End price
03.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bluebird Bio Inc. | - | - | - |
| iShares Core DAX® | -1.283% | 4.209% | 7.084% |
| iShares Nasdaq 100 | -3.338% | -1.744% | 26.177% |
| iShares Nikkei 225® | -4.286% | -1.621% | 44.320% |
| iShares S&P 500 | -2.311% | -0.096% | 20.823% |
Comments by Barclays_PLC for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) had its price target raised by analysts at Barclays PLC from $2.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for BLUE provided by MarketBeat
In the thread Trading Bluebird Bio Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten